DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
SEARCH
Current Location:
>
> This Story


Log in or Register to rate this News Story
Forward Printable StoryPrint Comment

 

Business Affairs Homepage

Shanghai Pharma to acquire Cardinal Health China business for $1.2 billion Deal includes pharma and medical products distribution business

ACR chair urges congress to fund low-dose radiation research Last BEIR report on effects of low-dose exposure issued over 10 years ago

GE to whittle down, focus more on health care CEO Flannery also plans to prioritize aviation and power businesses

First Lady of Mozambique visits KPI Healthcare headquarters Finalizing medical equipment contract to reduce mortality in African nation

Konica Minolta signs group purchasing agreement with Premier for the Exa platform The three-year deal brings special pricing to 3,900 hospitals

Siemens Healthineers IPO: New details from CEO, Joe Kaeser Internal preparations expected to conclude by March

Mike Kaufmann Cardinal Health names new CEO

Why employers with dispersed workforces should care about physician quality Lower quality treatment yields higher systemwide expenses

Imaging departments stay afloat during hurricanes Advice from the front lines of Harvey and Irma

Stryker partners with Philips to offer new and reprocessed ECG leads for one low price May divert millions of pounds of waste from landfills per year

Konica Minolta to acquire Ambry Genetics in $1 billion deal

by Thomas Dworetzky , Contributing Reporter
A Konica Minolta subsidiary is acquiring Aliso Viejo, California's Ambry Genetics in a $1 billion deal, the companies have announced.

The buy will be structured so that Konica Minolta, through Konica Minolta Healthcare Americas – a wholly owned subsidiary of Konica Minolta and Japanese state-backed Innovation Network Corporation of Japan (INCJ) – will pay $800 million to Ambry. Ambry shareholders will get up to $200 million in addition if “certain financial metrics” are met over the next two years, putting the deal's total worth at about $1.0 billion.

Story Continues Below Advertisement

Putting Your Enterprise Imaging Strategy in Place:

8 Tips for Selecting the Right Transformation Partner. As the healthcare industry moves toward a more personalized, value-based care model, choosing the right solution partner to obtain a truly transformational enterprise imaging strategy is paramount.



The deal is set to close in the third quarter of fiscal year 2017.

“This acquisition is the first in a series of strategic initiatives to secure a leading position for Konica Minolta in precision medicine,” Shoei Yamana said in a statement. “The future of medicine is patient-focused. Together with Ambry, we will have the most comprehensive set of diagnostic technologies for mapping an individual’s genetic and biochemical makeup, as well as the capabilities to translate that knowledge into information the medical community can use to discover, prevent, and cost-effectively treat diseases. This will not only serve as the future foundation for our health care business, but will pave the way for a fundamental shift in the way medicine is practiced globally.”

Konica Minolta plans to bring Ambry’s capabilities first to Japan, and then to Europe.

The deal is said to be the biggest ever done by Konica, according to Reuters.

Privately held Ambry was founded in 1999 by President and Chairman Charles L.M. Dunlop and CEO Dr. Aaron Elliott.

The company has a suite of genetic tests for inherited and non-inherited diseases, as well as for numerous clinical specialties, including oncology, cardiology, pulmonology, neurology, and general genetics. The firm has performed more than one million genetic tests and identified more than 45,000 mutations in at least 500 different genes.

“We’re excited by this opportunity to combine both our companies’ technologies to unlock new opportunities for precision medicine,” said Dunlop. “As a part of Konica Minolta, we will have the resources, technology, and scale to advance biomedical research and enable the matching of more patients in more countries with specialized medicines that target the underlying cause of their illness.”

Ambry’s capabilities fit in with Konica Minolta’s imaging technology to provide a “comprehensive range of health care diagnostics,” said the companies.
  Pages: 1 - 2 >>

Business Affairs Homepage


You Must Be Logged In To Post A Comment

Advertise
Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Directory
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Requests
Gold Service Dealer Program
Receive RFP/PS
Requests
Healthcare Providers
See all
HCP Tools
Jobs/Training
Find/Fill
A Job
Parts Hunter +EasyPay
Get Parts
Quotes
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Central
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Quotes
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2017 DOTmed.com, Inc.
ALL RIGHTS RESERVED